Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
26.77
-0.38 (-1.40%)
Apr 20, 2026, 1:50 PM EDT - Market open
Anbio Biotechnology Employees
Anbio Biotechnology had 27 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
27
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$320,253
Profits / Employee
$237,165
Market Cap
1.17B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 27 | 0 | - |
| Dec 31, 2024 | 27 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| DENTSPLY SIRONA | 14,000 |
| Azenta | 3,000 |
| Embecta | 1,850 |
| AtriCure | 1,350 |
| STAAR Surgical Company | 921 |
| LeMaitre Vascular | 655 |
| Kestra Medical Technologies | 330 |
| Alamar Biosciences | 222 |
NNNN News
- 9 months ago - Anbio Biotechnology Responds to Global Outbreaks with Chikungunya Rapid Test and New 15-Minute Ultra-Fast PCR System - GlobeNewsWire
- 1 year ago - Anbio Biotechnology to Showcase Global Diagnostic Innovations at Three Major May Exhibitions - GlobeNewsWire
- 1 year ago - Anbio Biotechnology Announces Closing of Initial Public Offering - GlobeNewsWire
- 1 year ago - Anbio Biotechnology Announces Pricing of Initial Public Offering - GlobeNewsWire